These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 34375111)

  • 1. Toward Guided Mutagenesis: Gaussian Process Regression Predicts MHC Class II Antigen Mutant Binding.
    Bell DR; Chen SH
    J Chem Inf Model; 2021 Oct; 61(10):4857-4867. PubMed ID: 34375111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of a Predictive Cleavage Motif for Eluted Major Histocompatibility Complex Class II Ligands.
    Paul S; Karosiene E; Dhanda SK; Jurtz V; Edwards L; Nielsen M; Sette A; Peters B
    Front Immunol; 2018; 9():1795. PubMed ID: 30127785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accurate pan-specific prediction of peptide-MHC class II binding affinity with improved binding core identification.
    Andreatta M; Karosiene E; Rasmussen M; Stryhn A; Buus S; Nielsen M
    Immunogenetics; 2015 Nov; 67(11-12):641-50. PubMed ID: 26416257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MultiRTA: a simple yet reliable method for predicting peptide binding affinities for multiple class II MHC allotypes.
    Bordner AJ; Mittelmann HD
    BMC Bioinformatics; 2010 Sep; 11():482. PubMed ID: 20868497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards universal structure-based prediction of class II MHC epitopes for diverse allotypes.
    Bordner AJ
    PLoS One; 2010 Dec; 5(12):e14383. PubMed ID: 21187956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved Prediction of MHC II Antigen Presentation through Integration and Motif Deconvolution of Mass Spectrometry MHC Eluted Ligand Data.
    Reynisson B; Barra C; Kaabinejadian S; Hildebrand WH; Peters B; Nielsen M
    J Proteome Res; 2020 Jun; 19(6):2304-2315. PubMed ID: 32308001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting CD4 T-cell epitopes based on antigen cleavage, MHCII presentation, and TCR recognition.
    Schneidman-Duhovny D; Khuri N; Dong GQ; Winter MB; Shifrut E; Friedman N; Craik CS; Pratt KP; Paz P; Aswad F; Sali A
    PLoS One; 2018; 13(11):e0206654. PubMed ID: 30399156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward the prediction of class I and II mouse major histocompatibility complex-peptide-binding affinity: in silico bioinformatic step-by-step guide using quantitative structure-activity relationships.
    Hattotuwagama CK; Doytchinova IA; Flower DR
    Methods Mol Biol; 2007; 409():227-45. PubMed ID: 18450004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved peptide-MHC class II interaction prediction through integration of eluted ligand and peptide affinity data.
    Garde C; Ramarathinam SH; Jappe EC; Nielsen M; Kringelum JV; Trolle T; Purcell AW
    Immunogenetics; 2019 Jul; 71(7):445-454. PubMed ID: 31183519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DM catalytically enhances peptide dissociation by sensing peptide-MHC class II interactions throughout the peptide-binding cleft.
    Reyes-Vargas E; Barker AP; Zhou Z; He X; Jensen PE
    J Biol Chem; 2020 Mar; 295(10):2959-2973. PubMed ID: 31969393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ab-initio conformational epitope structure prediction using genetic algorithm and SVM for vaccine design.
    Moghram BA; Nabil E; Badr A
    Comput Methods Programs Biomed; 2018 Jan; 153():161-170. PubMed ID: 29157448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graph-pMHC: graph neural network approach to MHC class II peptide presentation and antibody immunogenicity.
    Thrift WJ; Perera J; Cohen S; Lounsbury NW; Gurung HR; Rose CM; Chen J; Jhunjhunwala S; Liu K
    Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38555476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematically benchmarking peptide-MHC binding predictors: From synthetic to naturally processed epitopes.
    Zhao W; Sher X
    PLoS Comput Biol; 2018 Nov; 14(11):e1006457. PubMed ID: 30408041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach.
    Nielsen M; Lundegaard C; Worning P; Hvid CS; Lamberth K; Buus S; Brunak S; Lund O
    Bioinformatics; 2004 Jun; 20(9):1388-97. PubMed ID: 14962912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ.
    Karosiene E; Rasmussen M; Blicher T; Lund O; Buus S; Nielsen M
    Immunogenetics; 2013 Oct; 65(10):711-24. PubMed ID: 23900783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Planar molecular arrangements aid the design of MHC class II binding peptides].
    Cortés A; Coral J; McLachlan C; Benítez R; Pinilla L
    Mol Biol (Mosk); 2017; 51(3):524-533. PubMed ID: 28707669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Machine learning reveals a non-canonical mode of peptide binding to MHC class II molecules.
    Andreatta M; Jurtz VI; Kaever T; Sette A; Peters B; Nielsen M
    Immunology; 2017 Oct; 152(2):255-264. PubMed ID: 28542831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates.
    Morkowski S; Goldrath AW; Eastman S; Ramachandra L; Freed DC; Whiteley P; Rudensky AYu
    J Exp Med; 1995 Nov; 182(5):1403-13. PubMed ID: 7595211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico prediction of peptide-MHC binding affinity using SVRMHC.
    Liu W; Wan J; Meng X; Flower DR; Li T
    Methods Mol Biol; 2007; 409():283-91. PubMed ID: 18450008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of peptide binding patterns in different major histocompatibility complex/T cell receptor complexes using pigeon cytochrome c-specific T cell hybridomas. Evidence that a single peptide binds major histocompatibility complex in different conformations.
    Bhayani H; Paterson Y
    J Exp Med; 1989 Nov; 170(5):1609-25. PubMed ID: 2553848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.